Showing 121-130 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Optimizing islet cell graft performance with targeted alpha and beta cell composition and distribution | Mayo Clinic | Quinn Peterson | Cures | 01-April-2025 to 31-March-2027 | $699.138,64 |
| Designing a safe and effective strategy for T1D cell replacement therapy | The Regents of the University of California, San Francisco | Nur Shabrina Amirruddin | Cures | 01-March-2025 to 29-February-2028 | $264.895,00 |
| Prediction of Cancer Immunotherapy Precipitated Autoimmune Diabetes | The Regents of the University of California, San Francisco | Zoe Quandt | Cures | 01-March-2025 to 28-February-2030 | $1.000.000,00 |
| Single-arm intervention trial of TWIIST™ AID DEKA Loop insulin pump in pregnant women with pre-existing type 1 diabetes | Stanford University | Tugce Akcan | Improving Lives | 01-March-2025 to 28-February-2027 | $180.600,00 |
| Engineered Nanobodies to Visualize and Direct Antigen-Specific Tolerance in T1D | Boston Children’s Hospital | Novalia Pishesha | Cures | 01-March-2025 to 28-February-2030 | $999.999,00 |
| Investigating MAFA governed mechanisms underlying β-cell functional maturation and dysfunction using hPSC-derived β-cells | The Regents of the University of California, San Francisco | Veronica Cochrane | Cures | 01-July-2024 to 28-February-2027 | $231.222,03 |
| Prohormone convertase activity in human T1D pancreas tissue slices | University of Florida | Denise Drotar | Cures | 01-March-2025 to 29-February-2028 | $264.895,00 |
| Harnessing hematopoietic function in acute lymphoblastic leukemia to treat type 1 diabetes | Yale University | David Alagpulinsa | Cures | 01-March-2025 to 28-February-2030 | $991.634,17 |
| Longitudinal non-inasive monitoring of vascular remodeling using oxygen-sensing nanoprobes | Regents of the University of Michigan | Maria Coronel | Cures | 01-March-2025 to 28-February-2030 | $1.000.000,00 |
| Exploring the Effects of Beta Cell Regenerative Drugs on Cell Fate Decisions in Human Pancreatic Islets | Icahn School of Medicine at Mount Sinai | Esra Karakose | Cures | 01-March-2025 to 28-February-2030 | $999.999,00 |